Abstract
Although there are some recent studies which intent to address the spread of respiratory droplets through the air, these correspond to indoor conditions or outdoor situations which not take into account realistic scenario. Less attention has been paid to the spread of respiratory droplets in outdoor environments under microclimatologic turbulent wind and which is of growing importance given the current COVID-19 epidemic. We implement a computational model describing a sneezing person in an urban scenario under a medium intensity climatological wind. Turbulence was described with a wall-modeled Large Eddy Simulation model and the spread of respiratory droplets by using a lagrangian approach. Results show the spread of respiratory droplets is characterized by the dynamics of two groups of droplets of different sizes: larger droplets (400 – 900 μm) are spread between 2–5 m during 2.3 s while smaller (100 – 200 μm) droplets are transported a larger range between 8–11 m by the action of the turbulent wind in 14.1 s average. Given the uncertainty of potential contagion over this way and with this reach, these efforts are an intent to contribute to shine a light on the possibility of adopting stricter self-care and distancing measures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was founded by INCAR FONDAP Project N°15110027;CONICYT and MSET Chile SpA.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data available on request from the authors
